Developing Medical Cannabis Competencies: A Consensus Statement

Yuval Zolotov, Department of Health Systems Management, Faculty of Health Sciences, Ariel University, Israel.
Leslie Mendoza Temple, Integrative Medicine Program, Endeavor Health, Glenview, Illinois.
Richard Isralowitz, Regional Alcohol and Drug Abuse Research Center, Ben Gurion University of the Negev, Beer Sheva, Israel.
David A. Gorelick, Department of Psychiatry and Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore.
Rebecca Abraham, Northern Illinois University, DeKalb.
Donald I. Abrams, Department of Oncology, Zuckerberg San Francisco General Hospital and Trauma Center, University of California, San Francisco.
Kyle Barich, Holistic Industries LLC, Washington, District of Columbia.
Kevin F. Boehnke, Chronic Pain and Fatigue Research Center, Anesthesiology Department, University of Michigan, Ann Arbor.
Stephen Dahmer, Andrew Weil Center for Integrative Medicine, University of Arizona, Tucson.
Joseph Friedman, Scientific Advisory Board, Acannability, Chicago, Illinois.
Patricia Frye, Takoma Park Integrative Care, Takoma Park, Maryland.
Aviad Haramati, Georgetown University School of Medicine, Washington, District of Columbia.
Jade Isaac, University of Illinois College of Medicine, Chicago.
Mary Lynn Mathre, Patients Out of Time, Howardsville, Virginia.
Marion E. McNabb, Cannabis Center of Excellence, Inc., Boston, Massachusetts.
Melinda Ring, Osher Center for Integrative Health, Northwestern University, Chicago, Illinois.
Ethan B. Russo, CReDO Science, Vashon, Washington.
Deepika E. Slawek, Division of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York.
Brigham R. Temple, Divisions of Emergency Medicine and Immediate Care, Endeavor Health, Evanston, Illinois.
Genester S. Wilson-King, Victory Rejuvenation Center Inc, Lake Mary, Florida.
Julia H. Arnsten, Division of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York.
Mikhail Kogan, George Washington University, Washington, District of Columbia.

Document Type

Journal Article

Publication Date

10-1-2025

Journal

JAMA network open

Volume

8

Issue

10

DOI

10.1001/jamanetworkopen.2025.35049

Abstract

IMPORTANCE: The use of medical cannabis continues to expand rapidly across the US, yet most health care practitioners and trainees report feeling unprepared to counsel patients or integrate cannabis into care. Despite its clinical relevance, standardized education on medical cannabis remains absent from most medical school curricula. OBJECTIVE: To develop a consensus-based set of core competencies for educating medical students about medical cannabis, including its clinical utility, risks, legal landscape, and evidence base. EVIDENCE REVIEW: Between February and October 2023, a modified Delphi process was conducted with 23 experts representing a broad range of clinical and academic expertise. Through 2 rounds of anonymous, web-based surveys, panelists provided quantitative ratings and qualitative feedback on draft competencies. Competencies and subcompetencies were iteratively revised by the research team and re-evaluated by the panel. Final inclusion of competencies required a mean score of 4 or higher (on a 1 to 5 scale) on both importance and wording appropriateness. Subcompetencies were reviewed for comprehensiveness and educational value. FINDINGS: The expert panel included 14 physicians across multiple specialties, along with nurses, a pharmacist, and individuals with leadership roles in academic medicine. An initial list of 9 competencies was refined and consolidated into 6 core competencies: (1) understand the basics of the endocannabinoid system; (2) describe the main components of the cannabis plant and their biological effects; (3) review the legal and regulatory landscape of cannabis in the US; (4) describe the evidence base for health conditions that are commonly managed with cannabis; (5) understand the potential risks of medical cannabis use; and (6) understand basic clinical management with medical cannabis. Each competency is supported by 2 to 7 subcompetencies, resulting in 26 subcompetencies reflecting granular topics, such as patient safety, vulnerable populations, structural inequities, and interdisciplinary care. CONCLUSIONS AND RELEVANCE: These consensus-derived competencies provide a structured, evidence-informed foundation to guide the integration of medical cannabis into undergraduate medical education. Aligned with competency-based education principles, the implementation of the proposed framework can help ensure that future clinicians are equipped to provide informed, evidence-based, and patient-centered guidance on medical cannabis use.

Department

Medicine

Link to Full Text

Share

COinS